Health Condition 1: null- ASA grade I or II patient, Non diabetic, Non hypertensive and require catheterization
Conditions
Interventions
Intervention1: Darifenacin: Darifenacin 7.5 mg, orally 1 hour before the induction of anesthesia with sips of water
Intervention2: Solifenacin: Solifenacin 5 mg,orally 1 hour before the induction of a
Sponsors
Apollo Hospitals Bilaspur
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA grade I and II, 2.Non hypertensive and non diabetic 3.Scheduled for surgery under general anesthesia requiring catheterization
Exclusion criteria
Exclusion criteria: 1.patients with known sensitivity to study drugs, 2.history of drug or alcohol abuse, 3.history of chronic pain or daily intake of analgesics, 4.pregnant or breast-feeding females, 5.uncontrolled medical disease (diabetes mellitus and hypertension) 6.impaired kidney or liver functions and 7.psychiatric patients
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the effect of solifenacin and darifenacin for prevention of catheter-related bladder discomfortTimepoint: On arrival in the post anesthesia care unit (0 hr) and again at 1, 2, and 6 hr later. | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative fentanyl requirement Timepoint: Within 6 hr after completion of surgery | — |
Countries
India
Contacts
Public ContactDr Vinit Kumar Srivastava
Apollo Hospitals Bilaspur (C.G.) India
Outcome results
None listed